H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report) today and set a
Tag: Actinium Pharmaceuticals
William Blair Sticks to Its Buy Rating for Actinium Pharmaceuticals (ATNM)
In a report issued on January 13, Andy Hsieh from William Blair reiterated a Buy rating on Actinium Pharmaceuticals (ATNM
Actinium Pharmaceuticals (ATNM) Received its Third Buy in a Row
After H.C. Wainwright and William Blair gave Actinium Pharmaceuticals (NYSE MKT: ATNM) a Buy rating last month, the company received
Actinium Pharmaceuticals (ATNM) Received its Third Buy in a Row
After H.C. Wainwright and William Blair gave Actinium Pharmaceuticals (NYSE MKT: ATNM) a Buy rating last month, the company received
Maxim Group Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)
Maxim Group analyst Jason McCarthy reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report) yesterday and set a
Actinium Pharmaceuticals (ATNM) Received its Third Buy in a Row
After H.C. Wainwright and William Blair gave Actinium Pharmaceuticals (NYSE MKT: ATNM) a Buy rating last month, the company received
Actinium Pharmaceuticals (ATNM) Gets a Buy Rating from Maxim Group
In a report released yesterday, Jason McCarthy from Maxim Group reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research